GDTC · CytoMed Therapeutics Ltd
Market Cap
$10.75M
Shares
11.83M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-06-23 | — | |
| 6-K | 2026-06-03 | — | |
| 6-K | 2026-05-15 | — | |
| 6-K | 2026-05-11 | — | |
| 6-K | 2026-04-14 | — | |
| 20-F | 2026-03-31 | 2025-12-31 | |
| 6-K | 2026-03-31 | — | |
| 6-K | 2026-01-28 | — | |
| 6-K | 2026-01-13 | — | |
| 6-K | 2025-12-08 | — | |
| 6-K | 2025-11-18 | — | |
| 6-K | 2025-11-06 | — | |
| 6-K | 2025-10-22 | — | |
| 6-K | 2025-10-14 | — | |
| 6-K | 2025-10-02 | — | |
| 6-K | 2025-09-30 | 2025-06-30 | |
| 6-K | 2025-08-28 | — | |
| 6-K | 2025-08-19 | 2025-08-18 | |
| 6-K | 2025-07-21 | — | |
| 6-K | 2025-07-03 | — | |
| 6-K | 2025-07-03 | — | |
| 6-K | 2025-05-16 | — | |
| 20-F | 2025-04-28 | 2024-12-31 | |
| 6-K | 2025-04-28 | — | |
| 6-K | 2025-01-06 | — | |
| 6-K | 2024-12-05 | — | |
| 6-K | 2024-11-20 | — | |
| 6-K | 2024-10-07 | — | |
| 6-K | 2024-10-03 | — | |
| 6-K | 2024-09-30 | — | |
| 6-K/A | 2024-06-24 | — | |
| 6-K | 2024-06-20 | — | |
| 6-K | 2024-05-24 | — | |
| 6-K/A | 2024-04-25 | — | |
| 6-K | 2024-04-24 | — | |
| 20-F | 2024-04-22 | 2023-12-31 | |
| 6-K | 2024-03-18 | — | |
| 6-K | 2024-03-04 | — | |
| 6-K | 2024-01-29 | — | |
| 6-K | 2023-11-17 | 2023-06-30 | |
| 6-K | 2023-09-25 | — | |
| 6-K | 2023-08-01 | — | |
| 6-K | 2023-07-06 | — | |
| 20-F | 2023-05-01 | 2022-12-31 | |
| 6-K | 2023-04-18 | — |
Showing 1–45 of 45 filings